Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.850
+0.050 (2.78%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Market Cap
Serina Therapeutics has a market cap or net worth of $22.78 million as of April 28, 2026. Its market cap has decreased by -54.49% in one year.
Market Cap
22.78M
Enterprise Value
22.56M
1-Year Change
-54.49%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since March 27, 2024, Serina Therapeutics's market cap has decreased from $125.13M to $22.78M, a decrease of -81.79%. That is a compound annual growth rate of -55.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 22.17M | 8.65% |
| Dec 31, 2025 | 20.40M | -56.64% |
| Dec 31, 2024 | 47.05M | -62.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 26.52M |
| ABVC BioPharma | 26.44M |
| Barinthus Biotherapeutics | 26.22M |
| CEL-SCI | 25.90M |
| Tempest Therapeutics | 25.68M |
| Curis | 23.79M |
| Vistagen Therapeutics | 23.53M |
| Jasper Therapeutics | 23.47M |